Effects of peroxisome proliferators-activated receptor γ agonists on transforming growth factor-β1 and Smads signal pathway: Experiment with rat renal fibroblasts

National Medical Journal of China

Volumn 86, Issue 11, 2006, Pages 740-744

  Wang, Wei Ming ^a   Liu, Feng ^a   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Extracellular matrix; Peroxisomes; Smad; Transforming growth factor beta 1

Indexed keywords

CIGLITAZONE; FIBRONECTIN; LIGAND; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN J2; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TROGLITAZONE;

ANIMAL CELL; ARTICLE; CELL CULTURE; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXTRACELLULAR MATRIX; FIBROBLAST; KIDNEY; KIDNEY FAILURE; KIDNEY FIBROSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, FAR-WESTERN; CELLS, CULTURED; CHROMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; FIBRONECTINS; KIDNEY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PROSTAGLANDIN D2; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD PROTEINS; THIAZOLIDINEDIONES; TRANSFORMING GROWTH FACTOR BETA;

EID: 33646019832     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Zeisberg M, Strutz F, Muller GA. Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol, 2000, 13: S111-S120.
2. Chinese source. 2003, 12: 70-72.
3. Guan YF, Breyer MD. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. Kidney Int, 2001, 60: 14-30.
4. Chinese source. 2003, 86: 510-514.
5. Kasuga H, Ito Y, Sakamoto S, et al. Effects of anti-TGF-beta type II receptor antibody on experimental glomerulonephritis. Kidney Int, 2001, 60: 1745-1755.
6. Zeng F, Fornoni A, Elliot SJ, et al. Upregulation of type I collagen by TGF-β in mesangial cells is blocked by PPARγ activation. Am J Physiol Renal Physiol, 2002, 282: 639-648.
7. Baoling G, Daisuke K, Motohide I, et al. Peroxisome proliferators-activated receptor-γ ligands inhibit TGF-β1-induced fibronectin expression in glomerular mesangial cells. Diabetes, 2004, 53: 200-208.
8. Sawano H, Haneda M, Sugimoto T, et al. 15-Deoxy-Δ12, 14-prostaglandin J2 inhibits IL-1β-induced cyclooxygenase-2 expression in mesangial cells. Kidney Int, 2002, 61: 1957-1967.
9. Panzer U, Schneider A, Guan Y, et al. Effects of different PPARγ-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis. Kidney Int, 2002, 62: 455-464.
10. Chinese source. 2004, 20: 43-47.
11. Francisco J, Villarreal, Juan A. Peroxisome proliferators-activated receptors ligands, oxidative stress, and cardiac fibroblast extracellular matrix turnover. Hypertension, 2004, 44: 621-622.
12. Asano T, Wakisaka M, Yoshinari M, et al. Peroxisome proliferators-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation. Biochim Biophys Acta, 2000, 1497: 148-154.
13. Ye P, Hu X, Liu Y, et al. Activation of peroxisome proliferators-activated receptor alpha in human endothelial cell increases plasminiogens activator inhibitor type-1 expression. Chin Med J, 2003, 116: 29-33.
14. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell, 2003, 113: 685-700.
15. Leask A, Abraham DJ. TGF-β signaling and the fibrotic response. FASEB J, 2004, 18: 816-827.
16. Kathleen C, Flanders. Smad3 as a mediator of the fibrotic response. Int J Exp Path, 2004, 85: 47-64.
17. Wang W, Koka V, Lan HY. Transforming growth factor-β and Smad signaling in kidney diseases. Nephrology, 2005, 10: 48-56.